F ecal calprotectin and lactoferrin are sensitive markers of intestinal inflammation in IBD. They have been shown to correlate with clinical and endoscopic activity [1][2][3] and their prognostic value in detecting upcoming flares is increasingly being recognized. 4 Lamb et al investigated fecal cal
Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn’s Disease
✍ Scribed by Marco Scarpa; Renata D’Incà; Daniela Basso; Cesare Ruffolo; Lino Polese; Eugenia Bertin; Alessia Luise; Mauro Frego; Mario Plebani; Giacomo C. Sturniolo; Davide F. D’Amico; Imerio Angriman
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 266 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Fecal calprotectin and lactoferrin are promising noninvasive biomarkers for intestinal inflammation. In Crohn's disease (CD), during anti-TNF-alpha (TNF-␣) treatment, the clinical significance of these markers has, however, been insufficiently explored. Methods: Among CD patients receiv
Background: Correlation of endoscopic Crohn's disease activity with fecal calprotectin and lactoferrin is insufficiently studied. We evaluated the clinical significance of these neutrofil-derived proteins in assessment of Crohn's disease activity by comparing them with endoscopic disease activity an
## Background: The purpose of the study was to determine the role of fecal calprotectin and lactoferrin in the prediction of inflammatory bowel disease relapses, both in patients with ulcerative colitis (uc) and crohn's disease (cd), in a large, long-term, follow-up study. ## Methods: The prospec